Natcos Pharma Division located in Kothur Hyderabad India has now received Establishment Inspection Report (EIR) classifying the facility as Voluntary Action Indicated (VAI) from the U.S. Food and Drug Administration (FDA)
Natco Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release
September 18, 2025
Download PDF
Natco Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month